Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Oric Pharmaceuticals, Inc. ORIC

Healthcare  —  Biotechnology
13.16 (0.02) (0.15%) as of 25 Sep
Market cap
$1.4B
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio 10.20 16.84 16.81 32.96 15.88 13.68 10.39 10.56 14.13
Net Debt/EBITDA 1.19 1.99 3.24 4.03 3.09 2.25 1.80 1.71 1.95
Debt/Assets 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income 0.95 0.97 0.88 0.61 0.76 0.84 0.85 0.88 0.86
Capex/Depreciation 0.00 (0.58) (0.75) (0.53) (0.42) 27.34 0.17 0.17 0.66
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 40.78% 39.55% 34.80% (73.82%) (27.98%) (35.99%) (45.11%) (54.73%) (41.27%)
ROA (57.40%) 0.00% (57.14%) (37.50%) (26.34%) (32.66%) (40.34%) (48.60%) (37.91%)
ROIC 0.00% 0.00% 0.00% 0.00% (136.94%) (356.70%) (435.43%) 0.00% (86.88%)
Return on Tangible Assets (81.89%) (48.95%) (30.94%) (25.44%) (34.56%) (44.94%) (51.64%) (53.20%) (47.87%)
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue — 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share (0.70) (12.23) (12.80) (2.09) (1.59) (1.95) (1.68) (1.63) (1.27)
Cash per Share 0.86 24.59 46.95 13.38 6.24 5.20 4.05 3.67 3.21
Shareholders Equity per Share 0.86 0.00 (47.44) 13.21 7.19 5.61 4.36 3.49 4.38
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 0.86 0.00 (47.44) 13.21 7.19 5.61 4.36 3.49 4.38
Free Cash Flow (20.83) (21.21) (24.30) (45.93) (60.48) (77.22) (86.54) (113.85) (111.68)
Working Capital 24.00 41.13 84.65 287.70 225.37 195.07 192.14 237.40 268.05
Capital Expenditures (0.49) (0.52) (0.77) (0.67) (0.94) (2.08) (0.85) (1.19) (0.71)
Net Current Asset Value 22.31 43.72 (94.18) 287.48 214.86 185.63 184.68 231.23 263.94
Other line items
Quick Ratio 9.89 16.42 16.65 32.62 15.64 13.40 10.18 10.30 13.79
Depreciation/Fixed assets 0.29 0.36 0.46 0.64 0.93 (0.02) (1.79) (2.39) (0.45)
Cash ROIC (46.05%) (54.41%) 2,786.38% (8.10%) (12.15%) (18.29%) (20.48%) (23.16%) (17.03%)
Accounts Payable Turnover 1.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover 0.00 0.00 0.00 0.00 0.00 0.00 — — —
Average Days of Payables 381.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand 0.00 0.00 0.00 0.00 0.00 0.00 — — —
Revenue per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share (0.70) (11.93) (12.39) (2.06) (1.57) (1.89) (1.67) (1.62) (1.26)
Capex per Share 0.00 (0.30) (0.40) (0.03) (0.02) (0.05) (0.02) (0.02) (0.01)
Average Payables 0.69 0.69 0.30 0.45 1.32 1.60 1.13 1.25 2.69
Average Assets 38.38 0.00 47.05 196.55 298.82 272.91 249.59 263.07 341.52
Average Common Equity (54.02) (54.02) (77.25) 99.85 281.38 247.66 223.22 233.61 313.74
Capex to Sales — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates